|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.120 0.000 (0.000%) | 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 18,898 | 0.287% | 41,277 | 42,839 | 40,985 | 77,813 |
| Cost of Sales | (12,398) | -21.147% | (36,258) | (37,369) | (35,053) | (56,929) |
| Gross Profit | 6,500 | 108.267% | 5,019 | 5,470 | 5,932 | 20,884 |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (2,734) | 1,815 | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | (19,217) | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (1,131) | (21,889) | (10,796) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 186 | (153) | 3,588 | |
| Profit / (Loss) before Taxation | (4,458) | 99.107% | (20,332) | (11,407) | (94,158) | (111,064) | |
| Taxation | 10 | -- | (83) | 1,307 | 387 | 558 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 388 | -- | -- | -- | |
| Non-controlling Interests | (1,065) | 67.190% | 329 | (535) | 5,773 | 4,166 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (5,513) | 91.690% | (19,698) | (10,635) | (87,998) | (106,340) | |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 3,380 | 80.267% | 23,849 | 8,569 | 16,407 | 14,545 |
| Depreciation & Amortisation | 363 | 51.250% | 1,378 | 2,007 | 2,426 | 10,454 |
| Directors' Emoluments | -- | -- | 2,637 | 4,248 | 8,742 | 4,939 |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | Qualified | Qualified | Qualified | Unqualified (Modified Report) |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -2.170 | 38.217% | -0.110 | -0.060 | -49.000 | -61.750 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.050) | 0.026 | (0.204) | (0.001) |
| NBV per share ($) | (0.022) | -- | (1.086) | (0.940) | (0.919) | (0.788377) |
| Remarks: | Real time quote last updated: 06/03/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -5,513,000 |
| %Change | 91.690% |
| EPS / (LPS) | HKD -0.022 |
| NBV Per Share ($) | HKD -0.022 |